Answers are grounded in this paper and cite their sources.
Relapse of MDD was associated with increased total costs and health care utilization and lower adherence to antidepressants. Reducing the risk of relapse may result in a reduction of the associated health care burden; however, findings may only be generalizable to patients with commercial insurance.
No takes yet. Share an insight, caveat, or question.
Touya et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: